Introduction
Although often a desired and happy life event, pregnancy is a time of physical and emotional changes (1) (2) (3) (4) . Nausea and vomiting early in pregnancy (5) and physical changes later on (2) may affect women's quality of life.
As a generic measure of health-related quality of life, the 36-Item Short-Form Health Survey (SF-36) is widely used (6, 7) , also during pregnancy (1) (2) (3) (4) (8) (9) (10) . The Hospital Anxiety and Depression Scale (HADS) is a screening instrument to measure levels of anxiety and depression (11, 12) . During pregnancy in general, physical function decreases, whereas mental health status mainly remains ª 2016 Nordic Federation of Societies of Obstetrics and Gynecology, Acta Obstetricia et Gynecologica Scandinavica 96 (2017) [190] [191] [192] [193] [194] [195] [196] [197] stable or increases slightly (1, 2, 8, 9) . Depressive symptoms seem to be stable or increase over the course of pregnancy (1, 4, 13, 14) .
Pregestational diabetes in pregnancy is still associated with adverse maternal and neonatal pregnancy outcomes (15) . Strict glycemic control and appropriate gestational weight gain is important to obtain a normal pregnancy outcome in both women with type 1 and type 2 diabetes (16) (17) (18) . The management of pregestational diabetes in pregnancy presents extra daily challenges with lifestyle interventions, frequently measured self-monitored plasma glucose values and intensive insulin therapy. These great demands along with the fear of adverse outcomes may have a negative impact on quality of life and mental health. Poorer mental health in early pregnancy is associated with preterm delivery in women with pregestational diabetes (19) but whether there are changes in mental health during pregnancy still needs to be investigated. There are few quantitative studies on physical and mental health in pregnant women with pregestational diabetes and these mainly evaluate physical and mental health at one point in pregnancy without the possibility of studying changes during pregnancy (20) (21) (22) (23) (24) .
The aim of this study was to explore longitudinal changes in health-related quality of life and anxiety and depressive symptoms throughout pregnancy in women with pregestational diabetes. A secondary objective was to identify factors with potential influence on changes in physical and mental health.
Material and methods
The women included in this study participated in a randomized controlled trial on real-time continuous glucose monitoring in pregnancy in women with pregestational diabetes conducted in 2009-2011 (25) . They were referred to our Center for Pregnant Women with Diabetes before 14 completed gestational weeks with the diagnosis of diabetes before pregnancy. All Danish-speaking singleton pregnant women were eligible for participation with only few exclusion criteria, i.e. diabetic nephropathy or other concurrent severe diseases, or severe mental or psychiatric barriers (n = 4), as judged by the local diabetologist (25) . The inclusion rate was 79% for women with type 1 diabetes (n = 123) and 67% for women with type 2 diabetes (n = 31); 47 women declined to participate. The women were randomized at first pregnancy visit (mean 8 weeks) to real-time continuous glucose monitoring in addition to routine pregnancy care (n = 79) or routine care only (n = 75). Similar results on glycemic control, quality of life, anxiety and depression were observed in the two study arms, in both early and late pregnancy, and data were therefore merged for analyses in the present study.
Women who had a miscarriage (n = 5) or did not complete the SF-36 and/or HADS questionnaires adequately (n = 12) were excluded from the present study. A total of 137 pregnant women with type 1 (n = 110) and type 2 diabetes (n = 27) were included in the final analysis.
All women followed routine pregnancy care for women with pregestational diabetes as previously described (25) , and clinical characteristics were prospectively recorded as part of routine care. Ten women (7%) were treated with antidepressant medication at some point in pregnancy, seven with selective serotonin reuptake inhibitors and three with selective norepinephrine reuptake inhibitors.
Glycated hemoglobin (HbA1c) was measured on a DCA 2000 analyzer by a latex immunoagglutination inhibition method (DCS 2000; Bayer, Mishawaka, IN, USA). Urinary albumin excretion was measured as albumin-tocreatinine ratio in a random urine sample. A ratio ≥30 mg/mmol was defined as elevated. Total gestational weight gain was calculated as the difference between the last body weight measured before delivery and selfreported pregestational body weight.
Main outcome measures were patient-reported. At 8 and 33 gestational weeks, all women completed two internationally validated questionnaires (but not validated in the Danish pregnant population) concerning healthrelated quality of life (36-Item Short-Form Health Survey, SF-36) and psychological well-being (HADS) (19) and a non-validated questionnaire on nausea and vomiting (26) . Educational level was classified in accordance with the International Standard Classification of Education (27) and converted to three educational levels: ≤10 years, 11-14 years and ≥15 years of education.
Health-related quality of life was measured by the Danish version 1 of the SF-36 survey (7) . SF-36 consists of 36 items covering eight subscales of health: Physical Functioning, Role-Physical (role limitations due to physical health), Bodily Pain, General Health, Vitality, Social Functioning, Role-Emotional (role limitations due to emotional problems), and Mental Health. Each subscale ranges from 0 to 100. A higher score indicates better health. The eight subscales can be aggregated into two summary scores: the Physical Component Summary and
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This study explored health-related quality of life, anxiety and depression symptoms from early to late pregnancy in women with pregestational diabetes. Physical quality of life deteriorated while mental quality of life improved slightly. The results on mental health are reassuring. the Mental Component Summary, both standardized to the American general population with a mean of 50 and a standard deviation of 10.
Anxiety and depression symptoms were measured by the HADS questionnaire (11, 12) . The 14-item questionnaire contains two seven-item subscales that measure anxiety and depression symptoms. For each of the two subscales, a total score was obtained by adding the scores of the seven items in each subscale. The total scores of each subscale range from 0 to 21, a higher score indicating more symptoms. Scores 8-10 and 11-21 indicate a borderline case and a definite case of either anxiety or depression, respectively (11, 12) . In the present study, a cut-off score of ≥8 was used.
The women answered the following three questions concerning nausea and vomiting: "How many times during the last week have you experienced nausea or loathing for food that made you eat less than usual?", "How many times during the last week have you eaten more to prevent or reduce nausea?" "How many times during the last week did you vomit?". Women who reported eating less and/or more during the previous week ≥1 time due to or to prevent nausea were classified as having nausea and women who reported vomiting ≥1 time during the previous week were classified as experiencing vomiting (26) .
This report is based on a secondary analysis of data included in the original trial protocol (NCT00994357), which was approved by The Danish National Committee 
Statistical analyses
Differences in clinical characteristics between 8 and 33 gestational weeks were analyzed using McNemar's test and Wilcoxon signed rank test when appropriate. Clinical characteristics were given as number (%) or median (range) and SF-36 and HADS scores as means (AESD). Paired t-test was used to evaluate changes in SF-36 and HADS scores, and McNemar's test was used for the categorical outcome of HADS. The magnitude of score differences during pregnancy was evaluated by standardized effect sizes, defined as mean difference divided by the standard deviation at baseline (28, 29) . Effect sizes between 0.2 and 0.5 were classified as small, 0.5-0.8 as moderate and >0.8 as large, in accordance with Cohen (28) . Independent associations between Physical or Mental Component Summary scores at baseline and clinical variables were examined using multiple linear regression. Selection of potential confounding variables was based on clinical and theoretical considerations: HbA1c (%) at 8 gestational weeks, insulin dose (IU/kg/ 24 h) at 8 gestational weeks, maternal age (years), diabetes duration (years), diabetic retinopathy (yes/no), pregestational body mass index (BMI) (kg/m 2 ), educational level (high social class was reference), presence of nausea or vomiting (yes/no) at 8 gestational weeks, nulliparity (yes/ no). All explanatory variables were retained in the models irrespective of statistical significance. The same analyses were performed for the changes during pregnancy in Physical and Mental Component Summary scores, including the variables mentioned above, except for HbA1c and insulin dose at 8 gestational weeks, and with the addition of gestational weight gain (kg), and HbA1c (%) and insulin dose (IU/kg/24 h) at 33 gestational weeks. The association between gestational weight gain and the change in Physical Component Summary score during pregnancy was evaluated with linear regression. SF-36 Mental Component Summary score was considered to represent and measure overall mental health better compared with the HADS scores and was therefore chosen a priori for the multiple linear regression analysis. All statistical analyses were performed using SPSS Statistics 22 (IBM Corp., Armonk, NY, USA) and SAS Enterprise Guide version 5.1 (SAS Institute, Cary, NC, USA).
Results
Clinical characteristics of 137 pregnant women with type 1 or type 2 diabetes are shown in Table 1 . HbA1c decreased during pregnancy from a median of 50 mmol/ mol (6.7%) to 43 mmol/mol (6.1%). The presence of nausea and vomiting was common in early pregnancy and declined during pregnancy (Table 1) .
Changes in health status during pregnancy
The scores for Physical Functioning, Role Physical, Bodily Pain and Physical Component Summary all decreased (worsened) during pregnancy (p < 0.0001 in all subscales), and all changes were classified as "large" estimated by effect size. In contrast, scores for Mental Health (p = 0.0009) and Mental Component Summary (p < 0.0001) increased (improved) from early to late pregnancy, with a magnitude of the changes classified as "small" and "moderate", respectively (Table 2) .
HADS anxiety score decreased (improved) during pregnancy (p = 0.04) but the effect size was less than 0.2, so the change was classified as not clinically relevant. There was no significant change in the number of women with HADS anxiety score ≥8. HADS depression score and the prevalence of women with HADS depression score ≥8 was stable from early to late pregnancy (Table 2) . Table 3) .
The Mental Component Summary score at 8 gestational weeks was associated with presence of nausea or vomiting (b = Table 3) .
Using multiple linear regression analysis, greater improvement in Mental Component Summary score from early to late pregnancy was seen with lower HbA1c at 33 gestational weeks (b = À3.7, p = 0.02) ( Table 3 ).
Nausea and vomiting
Among women with nausea in early pregnancy (n = 85) the mean changes in Mental or Physical Component summary score during pregnancy were comparable between women recovering from nausea (n = 47) and those with sustained nausea (n = 38) [mean change of 6.2 (11.6) vs. 7.2 (9.7) (p = 0.68) and À11.4 (8.8) vs. À13.6 (8.4) (p = 0.24), respectively]. Likewise, the mean changes in Mental or Physical Component summary score during pregnancy were comparable in those recovering from vomiting (n = 17) and those with sustained vomiting (n = 7) (data not shown).
Discussion
In this study in pregnant women with pregestational diabetes, we found that physical quality of life deteriorated during pregnancy, whereas mental quality of life improved slightly. Only minor changes in anxiety and depression symptoms were noted.
Consistent with results from previous studies in pregnant women in general, physical quality of life deteriorated during pregnancy (1, 2, 8, 9) . A large longitudinal study of pregnant women (1) found that mean scores for SF-36 Physical Functioning declined from 95 prior to pregnancy to 58 in late pregnancy. Another smaller study of pregnant women without diabetes, in which the SF-36 Health Survey was applied several times during pregnancy, found that scores for three of the SF-36 subscales Defined as albumin-to-creatinine ratio ≥30 mg/mmol in a random urine sample. declined during pregnancy (2); Physical Functioning, Role-Physical and Bodily Pain, whereas the remaining subscales were unchanged. These results correspond well with the results of our study. A slight increase in mental health during pregnancy has also been seen in one study in pregnant women without diabetes (8) , whereas Hueston et al. (2) and Haas et al. (9) did not find any changes. Gestational weight gain was calculated as the difference between the last weight measured before delivery and self-reported pregestational weight.
Two systematic reviews (13, 14) found no consistent changes in the prevalence of depression during pregnancy, with prevalence rates from 7.4 to 12.0% and from 11.0 to 8.5% from first to third trimester, respectively. Our findings in women with pregestational diabetes are in accordance with this, as we found a comparable prevalence of depression symptoms in early and late pregnancy. However, more recent papers covering pregnancy in general, found an increase in the prevalence of depressive symptoms up to 30% very late in pregnancy (1,4) .
The prevalence of women with a score of ≥8 (i.e. above the cut-off score) for HADS anxiety was higher than for depression and occurred in about one of five women in our study. This is consistent with previous results in pregnant women in general (30) .
To our knowledge this study is the first to evaluate changes in quality of life and mental health from early to late pregnancy in women with pregestational diabetes. Previous studies on the topic only include small numbers of pregnant women with diabetes, mainly evaluate mental health once in pregnancy and use different assessment tools with different scoring systems, making comparisons with the present study difficult (20) (21) (22) (23) (24) .
In the present study, mental quality of life and anxiety symptoms improved in late pregnancy, and depression symptoms remained stable. This may reflect that despite extra daily challenges during pregnancy, women with diabetes may have an increased sense of security due to frequent contact with healthcare professionals. Late pregnancy ultrasound examinations may also have reassured the women about carrying healthy infants without malformations, and diabetes management is generally less demanding in late pregnancy (26) .
In pregnant women, worse physical quality of life has previously been shown to be associated with higher pregestational BMI (1) . A previous study found that physical quality of life was worse in third trimester and decreased more in obese women than non-obese women (8) . In line with this, we observed that a greater deterioration in the Physical Component Summary score was associated with higher gestational weight gain. The excessive weight gain, in addition to the growing womb, may limit the daily activities, and the deterioration in the physical component of quality of life is probably a natural consequence. Preventing excessive gestational weight gain in women with pregestational diabetes might thus also preserve maternal physical health during pregnancy in addition to improving pregnancy outcome (16) (17) (18) .
Improvement in mental quality of life was associated with lower HbA1c at 33 gestational weeks in our study. Whether obtaining strict glycemic control in late pregnancy improves mental health or women with improved mental health find it easier to obtain strict glycemic control in late pregnancy cannot be deducted from this study. Surprisingly, longer duration of diabetes was associated with better mental health at baseline. It might be that women with longer diabetes duration are more used to the situation of being chronically ill and therefore have better mental health than women with shorter diabetes duration.
Not surprisingly, nausea and vomiting were associated with both lower Physical Component Summary score and Mental Component Summary score in early pregnancy, as also described in pregnant women in general (5). Nausea and vomiting impacts women's ability to maintain their day-to-day activities, and quality of life levels for women with nausea and vomiting have been found to be comparable to levels in people with chronic illnesses (5) . There may also be a reverse association that women with low mental health tend to report more physical symptoms. However, somewhat contra-intuitively, no difference in the mean change in Physical or Mental Component Summary score during pregnancy was found when comparing women recovering from nausea or vomiting with those with sustained nausea or vomiting. Unfortunately, nausea and vomiting were not evaluated in a validated questionnaire such as the Pregnancy-Unique Quantification of Emesis (PUQE), which might have increased the validity of the results.
Strengths of this study are the inclusion of a relatively large number of women with pregestational diabetes compared with previous studies, careful prospective collection of data, and use of internationally validated questionnaires in early and late pregnancy. Even though inclusion criteria in the original trial were broad to secure generality, four women with severe mental or psychiatric barriers were excluded and women who declined participation may have differed in mental and physical health from those who consented. We did not collect data on history of depression, partner/family support, social activities and pregnancy complications occurring before completion of the final questionnaire. Such data could potentially have influenced the findings in the multivariate linear regression analysis. The proportion of women with diabetes who did not complete the questionnaires was low and the study population can be regarded as representative of the pregnant population with diabetes. However, despite the inclusion of a large number of women for this patient category, in statistical terms the number of women investigated was small and there might be a potential lack of statistical power in some analyses. Comparable data from local pregnant women without diabetes were not available. However, the levels of physical and mental health scores in our study correspond well with those from previous studies in pregnant women and the prevalence of depression symptoms was generally low and comparable to that in pregnant women without diabetes (1) (2) (3) (4) 8, 10, 13, 14) . The two study arms in the original trial were comparable with regard to clinical data, quality of life, anxiety and depression, both in early and late pregnancy, and were therefore merged in this study. However, there might have been interactions with different variables, with potential differences in the longitudinal assessment of the outcomes, which we were not able to correct for. To conclude, these results indicate that women with pregestational diabetes do not necessarily become disheartened despite the extremely high demands they face during pregnancy, which we find reassuring. 
